Examination of utility in patients of unresectable or recurrent gastric cancer treated with paclitaxel or nab-paclitaxel or paclitaxel+ ramucirumab in our hospital
Takayuki Kii(Osaka Medical and Pharmaceutical University), Kazuhide Higuchi(Osaka University of Pharmaceutical Sciences), Ken Asaishi(Osaka Medical and Pharmaceutical University), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Toru Ikegami(Jikei University School of Medicine), Tetsuji Terazawa(Osaka Medical and Pharmaceutical University), M Aoki(Osaka Medical and Pharmaceutical University)
Cited by 1
Related Papers
Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants
|Digestive Endoscopy|2018|261
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system
|Cancer Science|2014|238
Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212
|European Journal of Surgical Oncology|2016|138
Learning curve for robotic-assisted surgery for rectal cancer: use of the cumulative sum method
|Surgical Endoscopy|2014|132
Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer
|Annals of Surgery|2017|121